Koene R A, Hoitsma A J
Academisch Ziekenhuis, afd. Nierziekten, Nijmegen.
Ned Tijdschr Geneeskd. 1997 Jul 26;141(30):1469-71.
Kidney transplantation guarantees a better quality of life than dialysis and is less costly. Transplantation without preceding dialysis is an attractive option. However, transplantation long before end-stage renal failure prolongs the period of exposure to immunosuppressive therapy, thereby increasing the risk of malignancy. Transplantation at one year before dialysis-dependency is expected would seem an acceptable compromise. Unfortunately, this option is purely theoretical because there is a long waiting-list due to the existing donor shortage. Patients are usually put on the waiting-list after dialysis has already been started. Extension of the list with pre-dialysis patients is currently only justifiable in exceptional cases. These limitations do not apply to patients who have received an offer of kidney donation from a living (related or unrelated) donor. In these patients transplantation can be done as soon as the creatinine clearance has reached a level of 10-12 ml per minute. More attention should be paid to this form of transplantation, because it can help to decrease the donor shortage.
肾移植比透析能保证更好的生活质量,且成本更低。在没有先行透析的情况下进行移植是一个有吸引力的选择。然而,在终末期肾衰竭很久以前就进行移植会延长免疫抑制治疗的暴露时间,从而增加患恶性肿瘤的风险。在预计依赖透析前一年进行移植似乎是一个可以接受的折衷方案。不幸的是,这个选择纯粹是理论上的,因为由于现有的供体短缺,有很长的等待名单。患者通常在已经开始透析后才被列入等待名单。目前,仅在特殊情况下将透析前患者列入名单才是合理的。这些限制不适用于已收到活体(亲属或非亲属)供体肾脏捐赠提议的患者。在这些患者中,一旦肌酐清除率达到每分钟10 - 12毫升的水平,就可以进行移植。应该更多地关注这种移植形式,因为它有助于减少供体短缺。